Tofacitinib 11mg modified-release tablets
- SNOMED code
38162311000001103- Active compound
- Tofacitinib
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 1 tablet, tablet
- Ingredients
- Tofacitinib citrate, ID: 704313003
— 11 mg
based on base substance
- Form & Route
- tabletmodified-release.oral
Modified-release tablet, Oral - Controlled drug
- No Controlled Drug Status
Products
Xeljanz 11mg modified-release tablets (Pfizer Ltd)
Xeljanz 11mg modified-release tablets
- SNOMED code
38101111000001109- Supplier
- Pfizer Ltd
- Licensed as
- Medicines - MHRA/EMA
- Availability restrictions
- None
- Licensed route
- Oral
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Xeljanz 11mg modified-release tablets (Pfizer Ltd) 28 tablet 4 x 7 tablets38101211000001103 ref. pack | 💯 Available Legal category: POM | 54150623490525415062345474 | NHS Indicative Price £690.3 | • Hospital |
| — |
Reference packs
Tofacitinib 11mg modified-release tablets 28 tablet
- SNOMED code
38101011000001108- Quantity and unit
- 28 tablet
- Packs